Skip to main content
Erschienen in: Die Radiologie 1/2018

08.06.2018 | Stroke Unit | Review

Mobile stroke unit use for prehospital stroke treatment—an update

verfasst von: PD Dr. S. Walter, A. Ragoschke-Schumm, M. Lesmeister, S. A. Helwig, M. Kettner, I. Q. Grunwald, K. Fassbender

Erschienen in: Die Radiologie | Sonderheft 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Acute ischemic stroke is a treatable disease. Moreover, there is increasing evidence supporting mechanical recanalization for large-vessel occlusion, even beyond a strict time window. However, only small numbers of patients receive causal treatment.

Methods

One of the main reasons that patients do not receive causal therapy is their late arrival at the correct target hospital, which, depending on the type of stroke, is either a regional stroke unit or a comprehensive stroke center for interventional treatment. In order to triage patients correctly, a fast and complex diagnostic work-up is necessary, allowing a stroke specialist to decide on the best therapy option. As treatment possibilities become more comprehensive with the need for individualized decisions, the gap between treatment options and practical implementation is increasing.

Results

The “mobile stroke unit” concept encompasses the administration of prehospital acute stroke diagnostic work-up, therapy initiation, and triage to the correct hospital using a specially equipped ambulance, staffed with a team specialized in stroke. The concept, which was conceived and first put into practice in Homburg/Saar, Germany, in 2008, is currently spreading with more than 20 active mobile stroke unit centers worldwide. The use of mobile stroke units can reduce the time until stroke treatment by 50% with a tenfold increase of patients treated within the first 60 min of symptom onset.

Conclusion

The mobile stroke unit concept for acute stroke prehospital management is spreading worldwide. Intensive research is still needed to analyze the best setting for prehospital stroke management.
Literatur
1.
Zurück zum Zitat Adeoye O, Hornung R, Khatri P, Kleindorfer D (2011) Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 42:1952–1955CrossRef Adeoye O, Hornung R, Khatri P, Kleindorfer D (2011) Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 42:1952–1955CrossRef
2.
Zurück zum Zitat Agyeman O, Nedeltchev K, Arnold M et al (2006) Time to admission in acute ischemic stroke and transient ischemic attack. Stroke 37:963–966CrossRef Agyeman O, Nedeltchev K, Arnold M et al (2006) Time to admission in acute ischemic stroke and transient ischemic attack. Stroke 37:963–966CrossRef
3.
Zurück zum Zitat Audebert H, Fassbender K, Hussain MS, Ebinger M, Turc G, Uchino K, Davis S, Alexandrov A, Grotta J, PRESTO Group (2017) The PRE-hospital stroke treatment organization. Int J Stroke 12(9):932–940CrossRef Audebert H, Fassbender K, Hussain MS, Ebinger M, Turc G, Uchino K, Davis S, Alexandrov A, Grotta J, PRESTO Group (2017) The PRE-hospital stroke treatment organization. Int J Stroke 12(9):932–940CrossRef
4.
Zurück zum Zitat Bowry R, Parker S, Rajan SS, Yamal JM, Wu TC, Richardson L, Noser E, Persse D, Jackson K, Grotta JC (2015) Benefits of stroke treatment using a mobile stroke unit compared with standard management: the BEST-MSU Study Run-In Phase. Stroke 46(12):3370–3374CrossRef Bowry R, Parker S, Rajan SS, Yamal JM, Wu TC, Richardson L, Noser E, Persse D, Jackson K, Grotta JC (2015) Benefits of stroke treatment using a mobile stroke unit compared with standard management: the BEST-MSU Study Run-In Phase. Stroke 46(12):3370–3374CrossRef
5.
Zurück zum Zitat Cerejo R, John S, Buletko AB, Taqui A, Itrat A, Organek N, Cho SM, Sheikhi L, Uchino K, Briggs F, Reimer AP, Winners S, Toth G, Rasmussen P, Hussain MS (2015) A mobile stroke treatment unit for field triage of patients for intraarterial revascularization therapy. J Neuroimaging 25(6):940–945CrossRef Cerejo R, John S, Buletko AB, Taqui A, Itrat A, Organek N, Cho SM, Sheikhi L, Uchino K, Briggs F, Reimer AP, Winners S, Toth G, Rasmussen P, Hussain MS (2015) A mobile stroke treatment unit for field triage of patients for intraarterial revascularization therapy. J Neuroimaging 25(6):940–945CrossRef
6.
Zurück zum Zitat Gomes JA, Ahrens CL, Hussain MS, Winners S, Rasmussen PA, Uchino K, Cleveland Pre-Hospital Acute Stroke Treatment Study Group (2015) Pre-hospital reversal of warfarin-related coagulopathy in intracerebral hemorrhage in a mobile stroke treatment unit. Stroke 46(5):e118–e120CrossRef Gomes JA, Ahrens CL, Hussain MS, Winners S, Rasmussen PA, Uchino K, Cleveland Pre-Hospital Acute Stroke Treatment Study Group (2015) Pre-hospital reversal of warfarin-related coagulopathy in intracerebral hemorrhage in a mobile stroke treatment unit. Stroke 46(5):e118–e120CrossRef
7.
Zurück zum Zitat Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, Kunz A, Koch P, Kellner PA, Gierhake D, Villringer K, Fiebach JB, Grittner U, Hartmann A, Mackert BM, Endres M, Audebert HJ, STEMO Consortium (2014) Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA 311(16):1622–1631CrossRef Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, Kunz A, Koch P, Kellner PA, Gierhake D, Villringer K, Fiebach JB, Grittner U, Hartmann A, Mackert BM, Endres M, Audebert HJ, STEMO Consortium (2014) Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA 311(16):1622–1631CrossRef
8.
Zurück zum Zitat Ebinger M, Kunz A, Wendt M, Rozanski M, Winter B, Waldschmidt C, Weber J, Villringer K, Fiebach JB, Audebert HJ (2015) Effects of golden hour thrombolysis: a Pre-hospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy. JAMA Neurol 72(1):25–30CrossRef Ebinger M, Kunz A, Wendt M, Rozanski M, Winter B, Waldschmidt C, Weber J, Villringer K, Fiebach JB, Audebert HJ (2015) Effects of golden hour thrombolysis: a Pre-hospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy. JAMA Neurol 72(1):25–30CrossRef
9.
Zurück zum Zitat Evenson KR, Foraker RE, Morris DL, Rosamond WD (2009) A comprehensive review of pre-hospital and in-hospital delay times in acute stroke care. Int J Stroke 4:187–199CrossRef Evenson KR, Foraker RE, Morris DL, Rosamond WD (2009) A comprehensive review of pre-hospital and in-hospital delay times in acute stroke care. Int J Stroke 4:187–199CrossRef
10.
Zurück zum Zitat Fassbender K, Walter S, Liu Y et al (2003) “Mobile stroke unit” for hyperacute stroke treatment. Stroke 34:e44CrossRef Fassbender K, Walter S, Liu Y et al (2003) “Mobile stroke unit” for hyperacute stroke treatment. Stroke 34:e44CrossRef
11.
Zurück zum Zitat Fassbender K, Balucani C, Walter S, Levine SR, Haass A, Grotta J (2013) Streamlining of pre-hospital stroke management: the golden hour. Lancet Neurol 12(6):585–596 (Review)CrossRef Fassbender K, Balucani C, Walter S, Levine SR, Haass A, Grotta J (2013) Streamlining of pre-hospital stroke management: the golden hour. Lancet Neurol 12(6):585–596 (Review)CrossRef
12.
Zurück zum Zitat Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL (2017) Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. Lancet Neurol 16(3):227–237CrossRef Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL (2017) Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. Lancet Neurol 16(3):227–237CrossRef
13.
Zurück zum Zitat Feigin VL, Norrving B, Mensah GA (2017) Global burden of stroke. Circ Res 120(3):439–448CrossRef Feigin VL, Norrving B, Mensah GA (2017) Global burden of stroke. Circ Res 120(3):439–448CrossRef
14.
Zurück zum Zitat Hov MR, Nome T, Zakariassen E, Russell D, Røislien J, Lossius HM, Lund CG (2015) Assessment of acute stroke cerebral CT examinations by anaesthesiologists. Acta Anaesthesiol Scand 59(9):1179–1186CrossRef Hov MR, Nome T, Zakariassen E, Russell D, Røislien J, Lossius HM, Lund CG (2015) Assessment of acute stroke cerebral CT examinations by anaesthesiologists. Acta Anaesthesiol Scand 59(9):1179–1186CrossRef
15.
Zurück zum Zitat Kim JT, Fonarow GC, Smith EE, Reeves MJ, Navalkele DD, Grotta JC, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Schwamm LH, Saver JL (2017) Treatment with tissue plasminogen activator in the golden hour and the shape of the 4.5-Hour time-benefit curve in the National United States Get With The Guidelines-Stroke Population. Circulation 135(2):128–139CrossRef Kim JT, Fonarow GC, Smith EE, Reeves MJ, Navalkele DD, Grotta JC, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Schwamm LH, Saver JL (2017) Treatment with tissue plasminogen activator in the golden hour and the shape of the 4.5-Hour time-benefit curve in the National United States Get With The Guidelines-Stroke Population. Circulation 135(2):128–139CrossRef
16.
Zurück zum Zitat Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M (2012) Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology 79(4):306–313CrossRef Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M (2012) Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology 79(4):306–313CrossRef
17.
Zurück zum Zitat Parker SA, Bowry R, Wu TC, Noser EA, Jackson K, Richardson L, Persse D, Grotta JC (2015) Establishing the first mobile stroke unit in the United States. Stroke 46(5):1384–1391CrossRef Parker SA, Bowry R, Wu TC, Noser EA, Jackson K, Richardson L, Persse D, Grotta JC (2015) Establishing the first mobile stroke unit in the United States. Stroke 46(5):1384–1391CrossRef
18.
Zurück zum Zitat Rai AT, Seldon AE, Boo S, Link PS, Domico JR, Tarabishy AR, Lucke-Wold N, Carpenter JS (2017) A population-based incidence of acute large vessel occlusions and thrombectomy eligible patients indicates significant potential for growth of endovascular stroke therapy in the USA. J Neurointerv Surg 9(8):722–726CrossRef Rai AT, Seldon AE, Boo S, Link PS, Domico JR, Tarabishy AR, Lucke-Wold N, Carpenter JS (2017) A population-based incidence of acute large vessel occlusions and thrombectomy eligible patients indicates significant potential for growth of endovascular stroke therapy in the USA. J Neurointerv Surg 9(8):722–726CrossRef
19.
Zurück zum Zitat Scholten N, Pfaff H, Lehmann HC, Fink GR, Karbach U (2013) Thrombolysis for acute stroke—a nationwide analysis of regional medical care. Fortschr Neurol Psychiatr 81:579–585CrossRef Scholten N, Pfaff H, Lehmann HC, Fink GR, Karbach U (2013) Thrombolysis for acute stroke—a nationwide analysis of regional medical care. Fortschr Neurol Psychiatr 81:579–585CrossRef
20.
Zurück zum Zitat Schwamm LH, Ali SF, Reeves MJ et al (2013) Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes 6:543–549CrossRef Schwamm LH, Ali SF, Reeves MJ et al (2013) Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes 6:543–549CrossRef
21.
Zurück zum Zitat Tong D, Reeves MJ, Hernandez AF et al (2012) Times from symptom onset to hospital arrival in the Get with the Guidelines–Stroke Program 2002 to 2009: temporal trends and implications. Stroke 43:1912–1917CrossRef Tong D, Reeves MJ, Hernandez AF et al (2012) Times from symptom onset to hospital arrival in the Get with the Guidelines–Stroke Program 2002 to 2009: temporal trends and implications. Stroke 43:1912–1917CrossRef
22.
Zurück zum Zitat Walter S, Kostopoulos P, Haass A et al (2010) Bringing the hospital to the patient: first treatment of stroke patients at the emergency site. PLoS ONE 5:e13758CrossRef Walter S, Kostopoulos P, Haass A et al (2010) Bringing the hospital to the patient: first treatment of stroke patients at the emergency site. PLoS ONE 5:e13758CrossRef
23.
Zurück zum Zitat Walter S, Kostopoulos P, Haass A et al (2012) Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol 11:397–404CrossRef Walter S, Kostopoulos P, Haass A et al (2012) Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol 11:397–404CrossRef
Metadaten
Titel
Mobile stroke unit use for prehospital stroke treatment—an update
verfasst von
PD Dr. S. Walter
A. Ragoschke-Schumm
M. Lesmeister
S. A. Helwig
M. Kettner
I. Q. Grunwald
K. Fassbender
Publikationsdatum
08.06.2018
Verlag
Springer Medizin
Erschienen in
Die Radiologie / Ausgabe Sonderheft 1/2018
Print ISSN: 2731-7048
Elektronische ISSN: 2731-7056
DOI
https://doi.org/10.1007/s00117-018-0408-2

Weitere Artikel der Sonderheft 1/2018

Die Radiologie 1/2018 Zur Ausgabe

Das könnte Sie auch interessieren

Passend zum Thema

ANZEIGE

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Die neue Leitlinie zur Behandlung von Herzklappenerkrankungen der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) ist ab jetzt als deutschsprachige Pocket-Leitlinien abrufbar. Die wichtigsten Neuerungen des Updates finden Sie hier von Prof. Dr. Helge Möllmann aus Dortmund für Sie zusammengefasst.

ANZEIGE

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Der interventionelle Verschluss des linken Vorhofohrs ist eine in den Leitlinien empfohlene Alternative zur oralen Antikoagulation bei Menschen mit Vorhofflimmern. Bei welchen Patientinnen und Patienten Sie konkret an diese Alternative denken sollten – dazu gibt Kardiologe PD Dr. Zisis Dimitriadis alltagstaugliche Tipps.

ANZEIGE

Abbott Structural Heart

Content Hub

Wir helfen Menschen mit Strukturellen Herzerkrankungen ihre Lebensqualität zu verbessern. Entdecken Sie unser einzigartiges Produktportfolio für ihre Patienten.

Abbott Medical GmbH